Table 4 Characterization of EBV latency profile in EBV-positive BPH samples.

From: Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues

Sample ID

EBNA-LP

EBNA-1

EBNA-2

EBNA-3A

EBNA-3B

EBNA-3C

LMP-1

LMP-2

LMP-2A

LMP-2B

EBER-1

EBER-2

BHRF-1

BZLF-1

BPH_03

+

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

āˆ’

+

BPH_05

āˆ’

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

āˆ’

+

BPH_14

+

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

āˆ’

+

BPH_16

+

+

+

+

+

+

āˆ’

+

+

+

+

+

+

+

BPH_20

āˆ’

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

āˆ’

+

BPH_21

+

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

+

+

BPH_23

+

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

āˆ’

+

BPH_28

+

+

+

āˆ’

āˆ’

āˆ’

+

+

+

+

+

+

āˆ’

+

  1. The latency profile was mapped based on the expression of the following latency-associated genes: EBNA-3B, EBNA-3A, EBNA-2, EBNA-1, LMP-2A, LMP-2, LMP-1, EBNA-LP, EBNA-3C, EBNA-2B, EBER-2, EBER-1, BZLF-1, and BHRF-1. The + and āˆ’ signs show the presence and absence of gene expression, respectively.